Cannabis Law Report

SEPTEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, has acquired the exclusive worldwide rights from Nanomerics Ltd. Mack, Chairman and CEO of Virpax.

Epilepsy 40

Epilepsy Research and Development Clinical Trials Chronic Pain 40

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

United Patients Group

OCTOBER 25, 2023

– Topical (Lotions, Balms, or Patches): Ideal for localized pain relief without systemic effects. As the world of medical cannabis continues to evolve, staying up to date on the latest research, legal developments, and medical applications is crucial for informed decision-making.

Marijuana 105

Marijuana Patients Research and Development Edibles 105

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Since the early 1990s, Israel has stood at the front line of cannabis medicalization.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Alchimia

JUNE 20, 2016

An important point to highlight is the study recently published on the Cannabis and Cannabinoid Research website (June 2016) which shows that orally taken CBD may turn into THC due to the action of the digestive juices in the stomach. CBD Crew has recently developed a strain – named CBD Therapy – with much more CBD than THC.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We This product candidate is being funded through a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS).

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

Cannabis Law Report

SEPTEMBER 6, 2021

The steadily aging population across the globe has played a significant role in driving the demand for medical cannabis as geriatric patients are more likely to develop chronic illnesses and require more physician visits. Key Topics Covered: 1 Preface. Key Topics Covered: 1 Preface. 2 Scope and Methodology. 3 Executive Summary.

Chronic Pain 66

Chronic Pain Research and Development Clinical Trials Epilepsy 66

Healer

JUNE 2, 2020

Webinar Research Topics. After years of working in the specialty of pediatric emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. She has a special interest in treating children with intractable epilepsy, autism, and cancer. Play video.

Research and Development 52

Research and Development Epilepsy Topical Education 52

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”). The studies are expected to begin in January of 2022.

Research and Development 40

Research and Development Clinical Trials Pharmaceutical Chronic Pain 40

WeedAdvisor

JANUARY 8, 2019

The drug’s status as a controlled substance meant that research into its anti-tumour potential was sparse. While research into the topic is rare, it is not non-existent. Research into CBD and epilepsy found that the former could have significant therapeutic benefits for the latter. Final Thoughts.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JANUARY 18, 2022

Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Well-tolerated with No Serious Adverse Findings. BERWYN, Pa.–(BUSINESS

Safety 40

Safety Chronic Pain Research and Development Pharmaceutical 40

Kind Meds (Cannabis Education Blog)

AUGUST 16, 2021

Everyone remembers the news story about the remarkable transformation of children with severe epilepsy , where their seizures were dramatically reduced or eliminated by just a little bit of cannabis tincture. Researchers continue to study CBD’s short-term neuroprotective effects in the brain for possible treatment of sports concussions.

Marijuana 111

Marijuana Chronic Pain Tincture Cannabinoids 111

Medicinal Marijuana Association

FEBRUARY 11, 2024

Additionally, CBD has demonstrated anti-seizure properties, making it a potential treatment for epilepsy. Furthermore, ongoing research indicates that CBD might have neuroprotective properties, potentially benefiting individuals with neurological disorders. Is There a Risk of Developing a Tolerance to CBD Over Time?

CBD 52

CBD Research and Development Topical Cannabinoids 52

MMJ Recs

FEBRUARY 3, 2021

CBD has been used for relief of conditions such as: Seizures disorders and epilepsy Chronic inflammation Chronic pain Psychosis or mental health disorders including anxiety and depression Nausea Migraine headaches Gastrointestinal disorders such as inflammatory bowel disease. One particular study also gave participants stress tests.

Cannabinoids 52

Cannabinoids Patients Blood Pressure Chronic Pain 52

Cannabis Law Report

JANUARY 4, 2022

Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Wainwright & Co.

Pharmaceutical 40

Pharmaceutical Research and Development Chronic Pain Epilepsy 40

The Joint Blog

JANUARY 20, 2021

In recent years, as more research and studies have been undertaken on the subject of marijuana, a range of new benefits have been discovered. In patients with epilepsy, Alzheimer’s, chronic pain conditions, and more, marijuana can once again be used. Cannabis and Benefits.

Marijuana 68

Marijuana Sleep Chronic Pain Research and Development 68

Cannabis Law Report

DECEMBER 28, 2021

These accomplishments include accelerated development of our existing product candidates, broadening our pipeline of product candidates, and utilizing grants where appropriate. Nanomerics’) has enabled the development of product candidates for central nervous system (‘CNS’) and anti-viral indications. Mack, Chairman and CEO of Virpax.

Pharmaceutical 40

Pharmaceutical Research and Development Clinical Trials Chronic Pain 40

PrestoDoctor

OCTOBER 13, 2023

Initially developed in the 1980s, Marinol was primarily used to alleviate symptoms associated with chemotherapy-induced nausea and vomiting. More research is necessary to fully understand its efficacy in different pain management scenarios. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Key Topics Covered: Chapter 1 Methodology and Scope. Research Methodology. Research Scope And Assumptions. Market Segmentation and Scope.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

OCTOBER 1, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials Chronic Pain 40

Otherside Farms

JULY 11, 2019

You may have taken the time to look into this topic and again, you may not have had the time to do so. According to Harvard University, scientific evidence supports the effectiveness of Cannabidiol in the treatment of the most serious forms of Lennox-Gastaut syndrome and Dravet syndrome, two childhood epilepsy syndromes.

Oil 13

Oil CBD Cannabinoids THC 13

Cannabis Law Report

NOVEMBER 10, 2021

You can find a great post to read on the said topic from company sites like Buena Vida Botanicals. But, if you have a medical condition, such as heart issues, kidney disease, epilepsy, or a weakened immune system due to cancer, avoid taking CBD oil without a doctor’s consultation. May Cause Injury To The Liver.

Oil 52

Oil CBD Research and Development Chronic Pain 52

Cannabis Law Report

JANUARY 6, 2020

The ongoing studies and research that focuses on CBD provide a very clear picture of how this compound can provide some health benefits relating to seizures, cancer, anxiety, pain, and inflammation. Some research studies have linked the endocannabinoid system has to the pathogenesis of autism. taking a dose. Reduce inflammation.

Oil 59

Oil CBD Sleep Research and Development 59

MMJ Recs

JUNE 25, 2024

Cannabis consumption for medical purposes has gained widespread acceptance in recent years, thanks to growing research supporting its efficacy in alleviating symptoms associated with numerous medical conditions. One of the key considerations when using cannabis for medical purposes is selecting the appropriate consumption method.

Consumption 52

Consumption Conditions Chronic Pain Tincture 52

MMJ Recs

JUNE 9, 2024

Qualifying conditions include chronic or debilitating diseases, including cancer, epilepsy, multiple sclerosis, Crohn’s disease, Parkinson’s disease, and post-traumatic stress disorder (PTSD), among others.

Access 52

Access Marijuana Patients Programs 52

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. Music by Desca.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Otherside Farms

JANUARY 17, 2020

The Food and Drug Administration allows the use of CBD to treat pain, anxiety, depression, nausea, and some types of epilepsy. Many use vapes while others use topical creams for the treatment of injuries; others use CBD oils and hemp leaves in their recipes as food ingredients. So, how does cannabis affect eating lifestyles?

Food 52

Food Research and Development Seed-To-Sale CBD 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas and topical lotions and creams.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Info

MARCH 12, 2019

In both Canada and the Netherlands, this issue was a hot topic of concern for several years. As a result, workers who do not protect their skin (and in some cases respiratory passages) when closely working with the plant do seem to develop negative physical reactions. Unfortunately, given the lack of research, not much more is known.

Research and Development 45

Research and Development Concentrates Cannabinoids Cannabis 45

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.

Research and Development 52

Research and Development Medicine Access Media 52

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Healer

JANUARY 17, 2022

More recently, breeders have developed varieties of cannabis that lack the enzymes responsible for converting CBGA into the other cannabinoids, resulting in fully mature flowers dominant in CBGA and low in THC and other cannabinoids. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development CBD 52